Previous 10 | Next 10 |
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024 PR Newswire RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...
2024-06-21 10:54:35 ET More on Avantor Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript Avantor, Inc. 2024 Q1 - Results - Earnings Call Presentation Avantor Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Avantor Historical earning...
Avantor® Appoints Corey Walker as President of Laboratory Solutions PR Newswire RADNOR, Pa. , June 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and adva...
Avantor® Releases 2024 Science for Goodness Sustainability Report PR Newswire Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of schedule RADNOR, Pa. , June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of m...
2024-06-09 23:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 06:00:09 ET Tycho Peterson from Jefferies issued a price target of $28.00 for AVTR on 2024-06-03 04:54:00. The adjusted price target was set to $28.00. At the time of the announcement, AVTR was trading at $24.08. The overall price target consensus is at $38.00...
2024-05-30 16:10:00 ET Summary The global market for GLP-1 therapies now looks on pace to top $100 billion. GLP-1 pioneers such as Eli Lilly, Novo Nordisk, could be joined by new players Amgen, Altimmune, Pfizer, Viking, Roche, and privately held Boehringer Ingelheim that have GLP...
Avantor® to Participate in Goldman Sachs Global Healthcare Conference PR Newswire RADNOR, Pa. , May 29, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life science...
2024-05-26 09:55:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...
Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions Conference PR Newswire RADNOR, Pa. , May 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...